A B S T R A C T Measurements of respiratory mechanics, arterial blood gases, and pulmonary vascular resistance were made before and 15 min after inhalation challenge with Ascaris suum extract in dogs with natural sensitivity to this antigen. 25 of 47 dogs were treated before inhalation challenge with a prostaglandin inhibitor (90 mg/kg of aspirin or 2 mg/kg of indomethacin by intravenous infusion). In response to the challenge, bronchospasm developed in approximately half (responders) of each group reflected by decreases in mean specific respiratory system conductance and arterial oxygen tenision. While the dogs were breathing room air, pulmonary vaseular resistance remained unchanged after antigen challenge in the responders not given aspirin or indomethacin, but increased significantly and was associated with a lesser degree of arterial hypoxemia in the responders pretreated with either of the prostaglandin inhibitors. Prevention of arterial hypoxemia by oxygen breathing blocked an increase in pulmoinary vascular resistance in four pretreated responiders. No changes in respiratory mechanies, pulmonary hemodyiianaies, or arterial blood gases were noted in the 21 dogs who did not develop bronchospasmi regardless of whether or not they wvere pretreated. 12 additional dogs in whom arterial hypoxemia was produiced by 10% oxygen breathing, showed an increase in pulmonary vaseular resistance that was not potentiated by pretreatment with aspirin in 6. We conclude that in acuite experimental canine asthma, vasodilator prostaglandins appear to blunt the hypoxic pulmonary vasoconstrictor response, thereby further compromising gas exchange btut preventing the development of pulmonary hypertension.
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INTRODUCTION
Pulmnonary hemodynamic abnormalities in bronchial asthma may be related to alveolar hypoxia secondary Received for p)blUiction 14 to ventilation-perfusion inequalities, the action of chemical mediators of the asthmatic response on the pulmonary circulation, or the mechanical effects of pulmonary hyperinflation. Acute alveolar hypoxia results in pulmonary vasoconstriction by a direct effect on pulmonary vascular smooth muscle or indirectly via intrapulmonary chemical mediators (1) . This response is blunted in patients with portal cirrhosis (2) , after infusion of endotoxins (3) , and in the bronchospasm-associated hypoxia of experimental canine asthma (4) . Infusion of endotoxin may stimulate production of vasodilator prostaglandins and oppose the hypoxic vasoconstriction, because prostaglandin inhibitors prevent this blunted response (5) . Synthesis, release and activation of vasoactive chemical mediators iincluding histamine, bradykinin, and prostaglandins occur in extrinsic asthma (6) . The synthesis of a vasodilator prostaglandin might serve to maintain the pulmonary vascular bed in a dilated state after antigen challenge (7) and to reduce pulmonary arterial hypertension resulting from alveolar hypoxia (8, 9) . In this investigation, we studied the effects of prostaglandin inhibitors on hypoxic ptulmonary vasoconstriction in an experimental canine asthma model.
METHODS
59 mongrel dogs (12-34 kg) were anesthetized with 25-50 mg/kg pentobarbital sodium intravenously and anticoagulated vith 5,000 U of heparin sulfate given as an intravenous bolus.
They were placed in the lateral decubituis position and intubated with an oral cuffed endotracheal tube. Transvenous phrenic nerve stimulation (10) was used to maintain a respiratory rate and tidal volume that resulted in a base-line pH between 7.35-7.45 U. The dogs inspired either room air, 10% oxygeni, or 80% oxygen in nitrogen depending on the type of experiment.
Heinodytianaic measurements and arterial blood gases. Catheters were placed in the left atrium, the pulmonary artery, and one of the carotid arteries. Pressures at these sites were measured xvith a strain gauge (type P23, Statham Corp., Puerto Rico) and referenced to the mid-chest level. Pulmonary blood flow was determined with the indicator diltution method by injection of indocyanin green into the pulmonary artery and sampling b)lood withdrawn from the carotid artery with a Gilford densitometer (model 103TR, Gilford Instrument Laboratories Inc., Oberlin, Ohio Respiratory resistance was determined by the forced oscillation method as follows: without previous sighing and immediately after discontinuation of phrenic nerve stimulation, the endotracheal tube was conniected via a no. 1 Fleisch pneumotachograph to a tube through which sinusoidal volume changes of 100 ml or less were forced on the respiratory system with a loud speaker at a frequency of 6 Hz. This resulted in peak to peak flow rates of <0.7 liter/s. addition, there was a significant increase in mean Paco2 and a significant decrease in pH (Tables I and  II) . However, mean pulmonary vascular resistance did not change significantly.
In the six nonresponders, no significant changes were seen in pulmonary hemodynamics, FRC, pulmonary mechanics, or arterial blood gas composition.
Four additional responders breathing 80% oxygen B R
showed a significant decrease in mean SGrs, but no
Nonresponders changes in any of the other parameters. Pao2 associated with an increased pulmonary vascular resistance. These changes were not apparent in the ng/100 ml (SD 3.7) three indomethacin-pretreated nonresponders.
In 12 dogs breathing 80% oxygen, the physiologic without aspirin or measurements were repeated 60 min after the aspirin of' the 12 animals infusion was completed. At this time, no changes lers. They showed from previous base line were noted except for a slight ean SGrs to 33% of but significant increase in mean carotid arterial presYo of base line. In sure and slight but significant decrease (<10%) in (14), and Gold et al. (15) have studied the immunological and mechanical features of experimental canine asthma induced by inhalation of Ascaris suum extract and described the transient changes in airway mechanics and ventilation. We chose this model for the study of the hypoxic pulmonary vasoconstrictor response and its modification by vasoactive mediators of the asthmatic response for the following reasons. First, antigen-induced bronchospasm in sensitized dogs differs from human bronchial asthma in that no pulmonary hyperinflation is observed, perhaps related to the use of general anesthesia (16) . Therefore, the canine asthma represents a convenient model to study the effects of' alveolar hypoxia and chemical mediators on the pulmonary circulation without having to consider the added effects of altered respiratory mechanics on pulmonary hemodynamics (17) . To eliminate the vascular effects of increased alveolar pressures, the hemodynamic measurements were made during a short period of apnea, a method which has previously been shown to result only in minimal increases in pulmonary arterial pressure of < 1 cm H20 (18) . Second, transvenous phrenic nerve stimulation can be easily carried out in anesthetized dogs, thereby avoiding the effects of positive pressure ventilation on the pulmonary circulation (18) . The hypoxia during bronchospasm in the antigenchallenged dogs resulted from a combination of alveolar hypoventilation and ventilation-perfusion inequalities. Although alveolar gas composition was not measured in these studies, the observed magnitude of the decrease in Pao2 after antigen challenge was felt to be an expression of marked mean alveolar hypoxia under these experimental conditions where the induced alterations in gas exchange resulted from airway obstruction.
Hypoxia and acidosis produce variable changes in pulmonary vascular resistance in anesthetized dogs (19, 20) , whereas in conscious dogs the resulting increase in pulmonary vascular resistance is more consistent (21) . Even though general anesthesia was used in our experiments, it probably did not alter the significance of the results because all dogs with arterial hypoxemia (secondary to bronchospasm or 10% oxygen breathing) received the same anesthetic agent in similar doses. Likewise, changes in the responses to hypoxia with time (9) were eliminated by making all measurements 15 min after the onset of bronchial challenge or 10% oxygen breathing. Only one episode of hypoxia was produced in any given animal to avoid the potentiation of hypoxic pulmonary vasoconstriction by repetitive exposure to low oxygen concentrations (22) .
Using the experimental canine asthma model, we previously showed that, in contrast to hypoxia inducedl by 10% oxygen breathing or mechanical airway obstruction with beads, hypoxia associated with induced asthma does not lead to an increase in pulmonary vascular resistance (4) . This suggested that elaboration of vasodilator chemical mediators during the asthmatic attack might have prevented the expected hypoxiarelated pulmonary vasoconstriction. Prostaglandins are known to be synthesized after antigen challenge in rat, guinea pig, and human lung tissues (23, 24) and therefore might play such a role. Although aspirin can exert inhibitory and other effects on enzyme and cellular systems, moderate concentrations of aspirin achieved by therapeutic dosages selectively inhibit prostaglandin synthesis (25, 26) . The aspirin and indomethacin dosages used and serum aspirin concentrations achieved in our study are comparable to those used in other canine (27) and human (28, 29) studies. All animals received heparin, a substance which may modify platelet aggregation and the chemical mediators released from the lungs (30); therefore, the remote possibility that heparin interfered directly with aspirin or indomethacin as a prostaglandin inhibitor cannot be excluded on the basis of our experiments. Prostaglandin inhibitors (31) have been helpful in studying the role of prostaglandins in the regulation of bronchial and pulmonary vascular smooth muscle tone. For example, asthmatic patients have increased sensitivity to inhaled prostaglandin F2a, a potent bronchial smooth muscle constrictor, and it is now felt that endogenous, locally produced prostaglandin F2a may play a contributing role in the pathogenesis of bronchial asthma (32) . Also, prostaglandin inhibitors can antagonize the contraction of isolated human bronchial muscle by prostaglandin F2,c (33) . This apparently beneficial effect of aspirin-like drugs is of interest in view of other reports on the use of prostaglandin inhibitors in the treatment of asthmatic patients (34) , as well as in experimental asthma (35) . It has been demonstrated that prostaglandin inhibitors can modify the resting tone of certain isolated smooth muscle preparations including pulmonary vessels (7, 36, 37) . Most recently, for example, aspirin and indomethacin have been used successfully to promote vasoconstriction of a patent ductus arteriosus in an infant (29) . We observed in our dogs that after aspirin or indomethacin infusion into the pulmonary artery there was an immediate rise in pulmonary arterial pressure and a slight increase in pulmonary vascular resistance lasting 30-60 min. These findings also suggest a modification of pulmonary vasomotor tone by prostaglandin inhibition under normoxic conditions. The role of prostaglaindins in the hypoxic pulmonary vasoconstrictor response has been controversial. Although it was initially reported that aspirin reduces the hiypoxic vasoconstrictor response (38) , subsequent studies lhave slhown opposite results, namely, a potentiation of hypoxic vasoconstriction by prostaglandin inhibition (7, 39, 40) . Recently, it has been demonstrated that the progressively diminishing hypoxic pulmonary vasocon striction occurring with repeated hypoxic challeniges in blood-perfused isolated dog lungs can be reversed by aspirin administration (41) . It has also been suiggested (27) Wlhereas the role of prostaglandins in the pulmonary vascular responise to low inspired oxygen concentrations may not have been established, prostaglandin inhibition has been clearly shown to unmask the bltunted hypoxic pulmonary vasoconstriction after endotoxin infusion (5) . Similarly, the failure of pulmonary vasoconstriction in bronchospasm-associated hypoxia in our canine asthma model seems to result from the presence of vasodilator prostaglandins such as prostaglandin E2 or '2, because pretreatment by aspirin or indomethacin was capable of unmasking the hypoxic ptulmonary vasoconstrictor response. That the increase of pulmonary vascular resistance in the responders was due to hypoxia and not to other mechanisms is strongly suiggested by the absence of ptulmonary vasoconstrictioin in the responders in whom hypoxia was prevented by oxygen administration. Whether vasodilator prostaglandins are synthesized by constricted airway smooth mtusele (42) or as part of the generalized asthmatic chemical mediator response after antigen challenige (6) cannot be concluded from these experiments.
For comparable degrees of' bronchospasm, we observed a significantly lesser decrease in Pao2 after antigen challenge in the aspirin-and indomethacinpretreated responders compared with the responders without pretreatment, probably relate(d to a more even matching of ventilation and perftusion when hypoxic puilmonary vasoconstriction was allowed to develop. Thuts, elaboration of vasodilator prostaglandins in broinchlial asthma might prevent the development of pllmonary arterial hypertension seondary to alveolar hypoxia at the expense of f'urther compromising gas exchanige and worsening arterial hypoxemia.
